SCHEMBL29330477

SCHEMBL29330477

O=C1CCN[C@H](c2ccccc2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRCP P42785 2/20 0.47
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
MEN1 O00255 1/20 0.38
GID4 Q8IVV7 1/20 0.38
BRD4 O60885 1/20 0.37
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
TSHR P16473 1/20 0.37
KDM1A O60341 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2707254 1.00 PRCP (0.47) PRCPGAAMAPTSMN1; SMN2USP2
Hydrochloric Acid SCHEMBL29116032 0.98 PRCP (0.46) PRCPGAAMAPTSMN1; SMN2USP2
Hydrochloric Acid SCHEMBL29116034 0.98 PRCP (0.46) PRCPGAAMAPTSMN1; SMN2USP2
Tert-Butyl Formate SCHEMBL28064897 0.84 PRCP (0.36) PRCPGAAMAPTSMN1; SMN2USP2
SCHEMBL24366501 0.81 PRCP (0.42) PRCPGAAMAPTALDH1A1TP53
SCHEMBL5406451 0.81 PRCP (0.42) PRCPGAAMAPTALDH1A1TP53
SCHEMBL2708297 0.81 PRCP (0.42) PRCPGAAMAPTALDH1A1TP53
Hydrochloric Acid SCHEMBL3717615 0.80 PRCP (0.41) PRCPGAAMAPTALDH1A1TP53
SCHEMBL5738919 0.80 PRCP (0.60) PRCPGAAMAPTSMN1; SMN2ALDH1A1
SCHEMBL6140740 0.80 PRCP (0.60) PRCPGAAMAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228478-A1 COMPOUNDS AND METHODS OF USE F12, C1R, ABCG2 PRCP 444/4885GAA 889/4885MAPT 2749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.